Proswell
Beijing
About Proswell
Founded in 2004, PROSWELL MEDICAL COMPANY is committed to developing a health business, creating an international brand of local CROs, and providing a range of quality services for drug R&D evaluation. Spring Proswell attaches great importance to the design of clinical research programs, proposes evasive plans for the characteristics of experimental drugs, improves research quality, speeds up work progress, and provides high-quality and efficient clinical research services. Spring Proswell has won recognition from pharmaceutical companies, clinical research institutions and experts for its deep professional background, rigorous work attitude and efficient service.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Estimated revenue: $1K – $10K
- Total funding: $15.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2022)
- Website: proswell.com.cn
- Phone: 400-618-0207
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/proswell-22424 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.